SpaceX's $123 Billion Lockup Test: The Largest Share Unlock in Market History Begins in August

The largest IPO in US history is about to face its first real stress test, and the indicator to watch is not in the earnings report — it is in the lockup calendar.

SpaceX (NASDAQ: SPCX) went public on June 11, 2026, raising $75 billion at $135 per share and commanding a $1.7 trillion market cap at listing^[1]. The deal was larger than all US IPOs from the prior two calendar years combined^[1]. Less than 5% of total shares were actually released into the public float at launch^[2]. The rest are locked — but not behind a standard 180-day cliff. SpaceX implemented a staggered release schedule, with tranches of roughly 7% unlocking at days 70, 90, 105, 120, and 135 after the IPO^[2].

The first major wave — between 20% and 30% of total shares — hits approximately two trading days after the company reports Q2 earnings on August 4, 2026^[2][3]. By December 8, when the full 180-day period concludes, roughly 40% of all SpaceX shares will be freely tradable^[2]. Elon Musk’s personal stake carries a 366-day lockup, meaning his shares cannot be sold until approximately June 2027^[2].

Roughly 911.5 million shares, valued at approximately $123 billion at recent prices, will become eligible for trading through this staggered process^[2].

The supply-demand collision

SpaceX shares peaked at $225.64 shortly after the IPO, then entered a sustained decline^[3]. The stock fell below its $135 IPO price for the first time on July 15^[3]. On July 22, it hit an all-time low of $115.26, down 6.7% on the session^[3]. The company has shed roughly $250 billion from its IPO valuation, with its market cap falling to about $1.75 trillion from above $2.6 trillion at the peak^[3].

The concern is structural, not just directional. The first major unlock lands immediately after Q2 earnings — meaning the stock will simultaneously be digesting financial results and absorbing a massive supply increase. This is the pattern that early-warning indicators tend to flag: a liquidity event timed to a catalyst, where the market has no precedent for scale.

SpaceX joined the Nasdaq 100 just 15 trading days after its debut, a move expected to trigger over $4 billion in passive fund inflows^[4]. That passive demand may help absorb some unlocked supply, but the magnitude is untested.

The staggered unlock schedule

Sources: CryptoBriefing^[2], SpaceX IPO filings. Dates are approximate based on the disclosed day-count schedule.

Q2 was a record quarter — even without SpaceX

The IPO market staged a sharp recovery from Q1’s volatility spike. Forty-eight IPOs raised a record-breaking $104.8 billion in Q2 2026^[1]. Even excluding SpaceX, the quarter would have been the biggest for IPO proceeds since 2021, driven by a steady flow of large deals: nine other IPOs raised $1 billion or more, led by AI chipmaker Cerebras^[1].

Year-to-date, 86 IPOs have priced — down 23.2% from the prior year by deal count^[5], but proceeds are dramatically higher. The broader market saw 203 IPOs on US exchanges through July 20, a 6.84% increase over the same point in 2025^[6].

The pipeline behind the headline

The Q3 pipeline is building. Data center operator Csquare (CSQR) is set to raise $1.3 billion at a $3.9 billion market cap^[5]. Biotechs Braveheart Bio (BRVE) and Attovia Therapeutics (ATTO) have filed^[5]. Perhaps most significantly, Anthropic and OpenAI are among large issuers that have filed for IPO^[5] — deals that would extend the AI-issuance theme that defined Q2.

But the most recent deals have underwhelmed. Csquare and Standard Nuclear both priced amid a cautious market in the week of July 17^[5], a reminder that appetite is uneven even in a record year.

Secondaries hit record volume in parallel

While the IPO market dominates headlines, the private secondaries market is quietly setting records of its own. Secondary transaction volume reached $118 billion in the first half of 2026^[7], on top of $220 billion in full-year 2025^[7]. William Blair’s survey found “no signs of slowing in 2026”^[7].

The intersection matters. Record secondaries volume signals that private investors are seeking liquidity through alternative channels — and that the supply of shares looking for a home is growing across both public and private markets simultaneously.

What to watch next

1. SpaceX Q2 earnings (August 4): The first financial disclosure as a public company. Results will determine whether the first lockup wave meets a stock in recovery or in retreat.
2. First lockup tranche (~August 6): Approximately 20–30% of total shares become tradable. Trading volume and price impact in the days immediately following will signal whether the market can absorb the supply.
3. Second tranche timing (~October): The ~28% tranche tied to Q3 earnings. If the first wave causes disruption, the second will be watched closely.
4. Pipeline pricing: Watch whether Csquare’s aftermarket performance and upcoming biotech deals sustain or cool. The gap between filing and pricing is the real-time signal for market appetite.
5. Anthropic and OpenAI IPO timing: Any update on the AI mega-deals in the pipeline. These would be the next test of whether the market can absorb large-scale issuance after SpaceX.
6. Private secondaries trajectory: If H2 volume continues at the H1 pace, 2026 full-year secondaries could approach $240 billion, adding to the total supply of investable shares seeking buyers.